Lithium Citrate Syrup and Sodium phenylacetate and benzoate Intravenous
Determining the interaction of Lithium Citrate Syrup and Sodium phenylacetate and benzoate Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: sodium benzoate / sodium phenylacetate
Brand name: Ammonul
Synonyms: Sodium Phenylacetate and Sodium Benzoate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Citrate Syrup-Sodium Phenylacetate and Sodium Benzoate
- Lithium Citrate Syrup-Sodium Phenylacetate and Sodium Benzoate Injection
- Lithium Citrate Syrup-Sodium phenylbutyrate
- Lithium Citrate Syrup-Sodium Phenylbutyrate Powder
- Lithium Citrate Syrup-Sodium Phenylbutyrate Tablets
- Lithium Citrate Syrup-Sodium phosphate dibasic and sodium phosphate monobasic
- Sodium phenylacetate and benzoate Intravenous-Lithium Controlled-Release and Extended-Release Tablets
- Sodium phenylacetate and benzoate Intravenous-Lithium ER
- Sodium phenylacetate and benzoate Intravenous-Lithium Oral Solution
- Sodium phenylacetate and benzoate Intravenous-Lithium Salts
- Sodium phenylacetate and benzoate Intravenous-Lithium Syrup and Oral Solution
- Sodium phenylacetate and benzoate Intravenous-Lithobid